Trimethoprim pamoate

This classification denotes the pamoate form of a urinary anti-infective agent with the molecular formula C14H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AN164J8Y0X, chemically known as 2,4-pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)- but more generally known as trimethoprim, which bears US NIH Compound Identifier 5578. European Medicines Agency schedules Trimethoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11310MIG. The term TRIMETHOPRIM is an International Non-Proprietary Name World Health Organization schedules trimethoprim in its Anatomical Therapeutic Chemical (ATC) Classification. TRIMETHOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule trimethoprim pamoate under HS 29335995 and SITC 51576. SMILES: COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O.